Question 1

What Produces IGF-1? The GH-IGF Axis in Research

Accepted Answer

IGF-1 (insulin-like growth factor 1) is produced primarily in the liver in response to growth hormone (GH) signaling. The liver is responsible for the majority of circulating serum IGF-1 in mammals. Peripheral tissues including skeletal muscle, bone, cartilage, and kidney also synthesize IGF-1 locally, but hepatic production dominates systemic IGF-1 levels measured in blood. This GH-IGF-1 axis is a central research target in growth, metabolism, and aging model systems.

Question 2

The GH-IGF-1 Axis: How It Works

Accepted Answer

GH is secreted from the anterior pituitary gland in pulsatile bursts, primarily during sleep. When GH binds GH receptors on hepatocytes, it triggers JAK2-STAT5 signaling, which activates IGF-1 gene expression. The hepatocytes synthesize and secrete IGF-1 into the circulation. Circulating IGF-1 then acts on target tissues throughout the body via IGF-1 receptors (IGF-1R), a tyrosine kinase receptor that shares structural similarity with the insulin receptor. Negative feedback closes the loop: circulating IGF-1 suppresses GH secretion both at the pituitary and hypothalamic levels, and high GH also suppresses GHRH release from the hypothalamus. This feedback architecture is why growth hormone secretagogues studied in research models (like ipamorelin and CJC-1295) affect downstream IGF-1 levels as an indirect endpoint.

Question 3

Local vs Systemic IGF-1 Production

Accepted Answer

The distinction between hepatic (endocrine) IGF-1 and locally produced (autocrine/paracrine) IGF-1 is an active area in research. Peripheral tissues produce IGF-1 that acts locally without reaching significant systemic concentrations. Muscle IGF-1 in particular has been studied in exercise physiology models as a mediator of hypertrophic signaling, largely independent of the liver's hormonal IGF-1 output. This local production means that serum IGF-1 levels, while the standard research biomarker for GH axis activity, don't fully capture total IGF-1 signaling in a model organism.

Question 4

IGF-1 as a Research Biomarker

Accepted Answer

Serum IGF-1 is widely used as a pharmacodynamic biomarker for GH axis activity in research models. It's more stable in plasma than GH itself (which has a very short half-life), making it practical to measure from stored samples. ELISA kits for rodent and human IGF-1 are commercially available and well-validated for this purpose. Published literature using GH secretagogues typically reports both peak GH pulse and downstream IGF-1 levels as complementary endpoints. The GH pulse confirms receptor activation; the IGF-1 level confirms sustained downstream pathway activity.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research

What Produces IGF-1? Frequently Asked Questions

Explore Full Research Index